Prospera Financial Services Inc Baxter International Inc Transaction History

Prospera Financial Services Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$37.32 - $49.29 $9,815 - $12,963	263 Added 5.09%	5,431 $204,000
Q2 2023 Aug 08, 2023	SELL	$39.98 - $47.68 $36,381 - $43,388	-910 Reduced 14.97%	5,168 $235,000
Q1 2023 May 12, 2023	BUY	$37.58 - $52.57 $3,307 - $4,626	88 Added 1.47%	6,078 $246,000
Q4 2022 Feb 08, 2023	SELL	$49.7 - $57.71 $596,002 - $692,058	-11,992 Reduced 66.69%	5,990 $305,000
Q3 2022 Oct 27, 2022	BUY	$53.86 - $66.8 $755,763 - $937,337	14,032 Added 355.24%	17,982 $968,000
Q2 2022 Aug 08, 2022	SELL	$63.83 - $80.0 $82,787 - $103,760	-1,297 Reduced 24.72%	3,950 $254,000
Q1 2022 May 04, 2022	BUY	$76.85 - $89.45 $45,264 - $52,686	589 Added 12.64%	5,247 $407,000
Q4 2021 Feb 10, 2022	BUY	$74.57 - $87.19 $94,554 - $110,556	1,268 Added 37.4%	4,658 $400,000
Q3 2021 Nov 12, 2021	BUY	$73.77 - $83.61 $250,080 - $283,437	3,390 New	3,390 $273,000
Q4 2020 Feb 12, 2021	SELL	$75.39 - $82.36 $72,826 - $79,559	-966 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$78.33 - $90.73 $75,666 - $87,645	966 New	966 $78,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.